SEC Form 4 · accession 0001213711-16-000003
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerry Treppel
Other
Period of report
Mar 17, 2016
Accepted (ET)
Mar 21, 2016 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2016 | S | 312,430 | $0.345 | D | 7,898,651 | D | |
| Common Stock | Mar 18, 2016 | S | 258,090 | $0.342 | D | 7,640,561 | D |
Table II — derivative securities
No Table II lines on this filing.